nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—Bronchial hyperreactivity—Memantine—Alzheimer's disease	0.094	0.114	CcSEcCtD
Oxandrolone—Bronchial hyperreactivity—Rivastigmine—Alzheimer's disease	0.0919	0.111	CcSEcCtD
Oxandrolone—Chronic obstructive pulmonary disease—Memantine—Alzheimer's disease	0.0858	0.104	CcSEcCtD
Oxandrolone—Chronic obstructive pulmonary disease—Rivastigmine—Alzheimer's disease	0.084	0.102	CcSEcCtD
Oxandrolone—Hirsutism—Donepezil—Alzheimer's disease	0.0465	0.0562	CcSEcCtD
Oxandrolone—Necrosis—Memantine—Alzheimer's disease	0.0313	0.0378	CcSEcCtD
Oxandrolone—Creatinine increased—Donepezil—Alzheimer's disease	0.0284	0.0343	CcSEcCtD
Oxandrolone—Creatinine increased—Memantine—Alzheimer's disease	0.0258	0.0312	CcSEcCtD
Oxandrolone—Fluid retention—Rivastigmine—Alzheimer's disease	0.0228	0.0276	CcSEcCtD
Oxandrolone—Neoplasm—Memantine—Alzheimer's disease	0.0222	0.0268	CcSEcCtD
Oxandrolone—Neoplasm—Rivastigmine—Alzheimer's disease	0.0217	0.0262	CcSEcCtD
Oxandrolone—Irritability—Donepezil—Alzheimer's disease	0.0187	0.0226	CcSEcCtD
Oxandrolone—Blood creatinine increased—Donepezil—Alzheimer's disease	0.0184	0.0222	CcSEcCtD
Oxandrolone—Haemoglobin—Galantamine—Alzheimer's disease	0.0176	0.0213	CcSEcCtD
Oxandrolone—Haemorrhage—Galantamine—Alzheimer's disease	0.0175	0.0212	CcSEcCtD
Oxandrolone—Irritability—Memantine—Alzheimer's disease	0.017	0.0206	CcSEcCtD
Oxandrolone—Blood creatinine increased—Memantine—Alzheimer's disease	0.0167	0.0202	CcSEcCtD
Oxandrolone—Erectile dysfunction—Memantine—Alzheimer's disease	0.0142	0.0171	CcSEcCtD
Oxandrolone—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.0139	0.0168	CcSEcCtD
Oxandrolone—Haemoglobin—Donepezil—Alzheimer's disease	0.0136	0.0165	CcSEcCtD
Oxandrolone—Haemorrhage—Donepezil—Alzheimer's disease	0.0136	0.0164	CcSEcCtD
Oxandrolone—Haemoglobin—Memantine—Alzheimer's disease	0.0124	0.015	CcSEcCtD
Oxandrolone—Haemorrhage—Memantine—Alzheimer's disease	0.0123	0.0149	CcSEcCtD
Oxandrolone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.0121	0.0146	CcSEcCtD
Oxandrolone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.0121	0.0146	CcSEcCtD
Oxandrolone—Danazol—CCL2—Alzheimer's disease	0.0116	0.276	CrCbGaD
Oxandrolone—Insomnia—Galantamine—Alzheimer's disease	0.0112	0.0136	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—RCAN1—Alzheimer's disease	0.0105	0.0801	CbGpPWpGaD
Oxandrolone—Oedema—Donepezil—Alzheimer's disease	0.00964	0.0117	CcSEcCtD
Oxandrolone—Allylestrenol—ESR1—Alzheimer's disease	0.00889	0.212	CrCbGaD
Oxandrolone—Oedema—Memantine—Alzheimer's disease	0.00875	0.0106	CcSEcCtD
Oxandrolone—Insomnia—Donepezil—Alzheimer's disease	0.00872	0.0105	CcSEcCtD
Oxandrolone—Trilostane—ESR1—Alzheimer's disease	0.00866	0.206	CrCbGaD
Oxandrolone—Oedema—Rivastigmine—Alzheimer's disease	0.00856	0.0104	CcSEcCtD
Oxandrolone—Insomnia—Memantine—Alzheimer's disease	0.00792	0.00957	CcSEcCtD
Oxandrolone—Insomnia—Rivastigmine—Alzheimer's disease	0.00774	0.00937	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—GRN—Alzheimer's disease	0.00719	0.0548	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—PLCB1—Alzheimer's disease	0.00512	0.039	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—ESR1—Alzheimer's disease	0.00467	0.111	CrCbGaD
Oxandrolone—Danazol—ESR1—Alzheimer's disease	0.00446	0.106	CrCbGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAQ—Alzheimer's disease	0.00429	0.0326	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—SOD1—Alzheimer's disease	0.00334	0.0255	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—PTK2B—Alzheimer's disease	0.00333	0.0254	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00305	0.0232	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—CREB1—Alzheimer's disease	0.0028	0.0214	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—ESR1—Alzheimer's disease	0.00265	0.0202	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00259	0.0198	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00259	0.0198	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.00251	0.0191	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—PPARG—Alzheimer's disease	0.00242	0.0184	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—ESR1—Alzheimer's disease	0.00235	0.0179	CbGpPWpGaD
Oxandrolone—Progesterone—ESR1—Alzheimer's disease	0.00231	0.0551	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.0022	0.0168	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—NOTCH1—Alzheimer's disease	0.00216	0.0164	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—INS—Alzheimer's disease	0.00211	0.0161	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.00209	0.0159	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.00207	0.0158	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00203	0.0155	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.00191	0.0145	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00186	0.0142	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.00184	0.014	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.00179	0.0136	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.00176	0.0134	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.00169	0.0129	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.00167	0.0127	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.00163	0.0124	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.00158	0.0121	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.00157	0.012	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.00155	0.0118	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.00153	0.0116	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.00153	0.0116	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.00148	0.0113	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.00145	0.0111	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.00145	0.011	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CAV1—Alzheimer's disease	0.00139	0.0106	CbGpPWpGaD
Oxandrolone—Progesterone—CYP2D6—Alzheimer's disease	0.00138	0.0328	CrCbGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.0013	0.00991	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.00129	0.00982	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.00127	0.00965	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.00124	0.00946	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—GSK3B—Alzheimer's disease	0.00122	0.00926	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CREB1—Alzheimer's disease	0.00121	0.00919	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.00117	0.00895	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00114	0.00869	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.00112	0.00856	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.0011	0.00834	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.00109	0.0083	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.00106	0.00807	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00101	0.00771	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.00097	0.00739	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000964	0.00734	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PHF1—Alzheimer's disease	0.000918	0.007	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000903	0.00688	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.000878	0.00669	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.00079	0.00602	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00077	0.00586	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000728	0.00554	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.000663	0.00505	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000655	0.00499	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—Alzheimer's disease	0.000654	0.00498	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.00063	0.0048	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—TFAM—Alzheimer's disease	0.000592	0.00451	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.000585	0.00446	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000571	0.00435	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.00057	0.00434	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.00055	0.00419	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.000522	0.00398	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.000521	0.00397	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	0.000496	0.00378	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.000485	0.00369	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000484	0.00368	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	0.000483	0.00368	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.000445	0.00339	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000414	0.00316	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.000411	0.00313	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.000378	0.00288	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	0.000375	0.00286	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.000361	0.00275	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EIF2S1—Alzheimer's disease	0.000356	0.00271	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.000353	0.00269	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000349	0.00266	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000334	0.00255	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.00033	0.00251	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	0.000317	0.00241	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.000311	0.00237	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.000262	0.002	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR1—Alzheimer's disease	0.000174	0.00133	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NOTCH1—Alzheimer's disease	0.000168	0.00128	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARG—Alzheimer's disease	0.000159	0.00121	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—Alzheimer's disease	6.28e-05	0.000478	CbGpPWpGaD
